Open Journal of Rheumatology and Autoimmune Diseases

Vol.2 No.3(2012), Paper ID 21767, 6 pages

DOI:10.4236/ojra.2012.23011

 

Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia

 

Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa

 

Division of Rheumatology, Milano, Italy
Division of Rheumatology, Milano, Italy
Division of Pulmonary and Critical Care Medicine
Department of Health Sciences Research
Department of Radiology, Mayo Clinic College of Medicine, Rochester , US
Division of Rheumatology, Brigham and Womens Hospital, Boston, US

 

Copyright © 2012 Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


E. Matteson, T. Bongartz, J. Ryu, C. Crowson, T. Hartman and P. Dellaripa, "Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 3, 2012, pp. 53-58. doi: 10.4236/ojra.2012.23011.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.